Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease

Antiviral Research

Volumn 94, Issue 1, 2012, Pages 72-79

  Nitsche, Christoph ^a   Behnam, Mira A M ^b   Steuer, Christian ^a   Klein, Christian D ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN UNIVERSITY IN CAIRO   (Egypt)

Author keywords

Dengue virus; Hybrid retro peptides; NS2B NS3 protease; Thrombin; West Nile virus

Indexed keywords

ANTIVIRUS AGENT; APROTININ; DIPEPTIDE DERIVATIVE; HYBRID PROTEIN; NS2B NS3 PROTEASE; PROTEINASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CATALYSIS; DENGUE VIRUS; DRUG DEVELOPMENT; DRUG SELECTIVITY; ELECTROPHILICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS;

ANTIVIRAL AGENTS; DENGUE; DENGUE VIRUS; HUMANS; PEPTIDES; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS;

DENGUE VIRUS; WEST NILE VIRUS;

EID: 84858145412     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.02.008     Document Type: Article

References (20)

1. Amarasinghe A., Kuritsky J.N., Letson G.W., Margolis H.S. Dengue virus infection in Africa. Emerg. Infect. Dis. 2011, 17:1349.
2. Bodenreider C., Beer D., Keller T.H., Sonntag S., Wen D., Yap L., Yau Y.H., Shochat S.G., Huang D., Zhou T., Caflisch A., Su X.C., Ozawa K., Otting G., Vasudevan S.G., Lescar J., Lim S.P. A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease. Anal. Biochem. 2009, 395:195-204.
3. Chorev M., Goodman M. Recent developments in retro peptides and proteins - an ongoing topochemical exploration. Trends Biotechnol. 1995, 13:438-445.
4. Diamond, S.L., 2011. Thrombin 1536 HTS, PubChem Bio-Assay ID 1046. Available from: (12.10.11). http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=1046&loc=ea_ras.
5. Franco C., Hynes N.A., Bouri N., Henderson D.A. The dengue threat to the United States. Biosecur. Bioterror. 2010, 8:273-276.
6. La Ruche G., Souares Y., Armengaud A., Peloux-Petiot F., Delaunay P., Despres P., Lenglet A., Jourdain F., Leparc-Goffart I., Charlet F., Ollier L., Mantey K., Mollet T., Fournier J.P., Torrents R., Leitmeyer K., Hilairet P., Zeller H., Van Bortel W., Dejour-Salamanca D., Grandadam M., Gastellu-Etchegorry M. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill. 2010, 15:19676.
7. Lescar J., Luo D., Xu T., Sampath A., Lim S.P., Canard B., Vasudevan S.G. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res. 2008, 80:94-101.
8. Li J., Lim S.P., Beer D., Patel V., Wen D., Tumanut C., Tully D.C., Williams J.A., Jiricek J., Priestle J.P., Harris J.L., Vasudevan S.G. Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. J. Biol. Chem. 2005, 280:28766-28774.
9. Nitsche C., Steuer C., Klein C.D. Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases. Bioorg. Med. Chem. 2011, 19:7318-7337.
10. Noble C.G., She C.C., Chao A.T., Shi P.Y. Ligand-bound structures of the dengue virus protease reveal the active conformation. J. Virol. 2012, 86:438-446.
11. Peterlin-Mašič L., Kikelj D. Arginine mimetics. Tetrahedron 2001, 57:7073-7105.
12. Pluskota B., Storch V., Braunbeck T., Beck M., Becker N. First record of Stegomyia albopicta (Skuse) (Diptera: Culicidae) in Germany. Eur. Mosquito Bull. 2008, 26:1-5.
13. Schüller A., Yin Z., Brian Chia C.S., Doan D.N.P., Kim H.-K., Shang L., Loh T.P., Hill J., Vasudevan S.G. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease. Antiviral Res. 2011, 92:96-101.
14. Steuer C., Heinonen K.H., Kattner L., Klein C.D. Optimization of assay conditions for dengue virus protease: effect of various polyols and nonionic detergents. J. Biomol. Screen. 2009, 14:1102-1108.
15. Steuer C., Gege C., Fischl W., Heinonen K.H., Bartenschlager R., Klein C.D. Synthesis and biological evaluation of alpha-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture. Bioorg. Med. Chem. 2011, 19:4067-4074.
16. Stoermer M.J., Chappell K.J., Liebscher S., Jensen C.M., Gan C.H., Gupta P.K., Xu W.J., Young P.R., Fairlie D.P. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity. J. Med. Chem. 2008, 51:5714-5721.
17. Yin Z., Patel S.J., Wang W.L., Wang G., Chan W.L., Rao K.R., Alam J., Jeyaraj D.A., Ngew X., Patel V., Beer D., Lim S.P., Vasudevan S.G., Keller T.H. Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead. Bioorg. Med. Chem. Lett. 2006, 16:36-39.
18. Yin Z., Patel S.J., Wang W.L., Chan W.L., Ranga Rao K.R., Wang G., Ngew X., Patel V., Beer D., Knox J.E., Ma N.L., Ehrhardt C., Lim S.P., Vasudevan S.G., Keller T.H. Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors. Bioorg. Med. Chem. Lett. 2006, 16:40-43.
19. Yusof R., Clum S., Wetzel M., Murthy H.M., Padmanabhan R. Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J. Biol. Chem. 2000, 275:9963-9969.
20. Zhao H., Cai M.Z., Peng C.Y., Song C.S. Palladium-catalysed arylation of butyl acrylate and acrylamide with aryl iodides in water. J. Chem. Res 2002, 28-29.